blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1398327

EP1398327 - Method of producing hydroxyalkyl starch derivatives [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  06.07.2012
Database last updated on 07.10.2024
Most recent event   Tooltip31.07.2015Change - lapse in a contracting state
State(s) deleted from list of lapses: NL		published on 02.09.2015  [2015/36]
Applicant(s)For all designated states
Fresenius Kabi Deutschland GmbH
Kabi Strategic Business Center
61346 Bad Homburg v.d.H. / DE
[2004/12]
Inventor(s)01 / Zander, Norbert
Zellbergsheideweg 45
38527 Meine / DE
 [2004/12]
Representative(s)Altmann, Andreas, et al
Herzog Fiesser & Partner Patentanwälte PartG mbB
Isartorplatz 1
80331 München / DE
[N/P]
Former [2010/37]Altmann, Andreas, et al
Herzog Fiesser & Partner Patentanwälte Isartorplatz 8
80331 München / DE
Former [2010/11]Altmann, Andreas
Herzog Fiesser & Partner Patentanwälte Isartorplatz 8
80331 München / DE
Former [2008/38]Wichmann, Hendrik
Isenbruck Bösl Hörschler Wichmann Huhn Patentanwälte Prinzregentenstrasse 68
81675 München / DE
Former [2004/12]Wichmann, Hendrik, Dr.
Patentanwälte Isenbruck Bösl Hörschler Wichmann Huhn Postfach 86 08 80
81635 München / DE
Application number, filing date03020424.211.09.2003
[2004/12]
Priority number, dateEP2002002042511.09.2002         Original published format: EP 02020425
US20020409781P11.09.2002         Original published format: US 409781 P
WO2003EP0882908.08.2003         Original published format: PCT/EP0308/829
[2004/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1398327
Date:17.03.2004
Language:EN
[2004/12]
Type: B1 Patent specification 
No.:EP1398327
Date:27.08.2008
Language:EN
[2008/35]
Search report(s)(Supplementary) European search report - dispatched on:EP12.12.2003
ClassificationIPC:C08B31/00, C07K14/505, A61K47/48
[2004/12]
CPC:
C08B31/12 (EP,KR,US); C08B31/10 (KR); A61K47/61 (EP,US);
A61K9/0021 (EP,US); A61P43/00 (EP); A61P7/00 (EP);
A61P7/06 (EP); C07K14/505 (EP,US); C07K14/53 (EP,US);
C07K14/5412 (EP,US); C07K14/55 (EP,US); C07K14/56 (EP,US);
C07K14/565 (EP,US); C07K17/10 (EP,US); C08B31/00 (EP,US);
C08B31/006 (EP,US); C08B31/08 (EP,US); C08B31/185 (EP,US);
C08H1/00 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/12]
TitleGerman:Verfahren zur Herstellung von Hydroxyalkylstärkederivaten[2004/12]
English:Method of producing hydroxyalkyl starch derivatives[2004/12]
French:Procédé de préparation des dérives d'amidon hydroxyalkyle[2008/09]
Former [2004/12]procede de preparation des derives d'amidon hydroxyalkyle
Examination procedure02.06.2004Examination requested  [2004/32]
24.03.2005Amendment by applicant (claims and/or description)
04.05.2005Despatch of a communication from the examining division (Time limit: M04)
05.09.2005Reply to a communication from the examining division
31.10.2005Despatch of a communication from the examining division (Time limit: M04)
27.02.2006Reply to a communication from the examining division
18.04.2006Despatch of a communication from the examining division (Time limit: M04)
12.07.2006Reply to a communication from the examining division
25.09.2006Despatch of a communication from the examining division (Time limit: M04)
05.02.2007Reply to a communication from the examining division
10.08.2007Despatch of a communication from the examining division (Time limit: M04)
13.12.2007Reply to a communication from the examining division
06.03.2008Communication of intention to grant the patent
15.07.2008Fee for grant paid
15.07.2008Fee for publishing/printing paid
Divisional application(s)EP08012908.3  / EP2017287
EP10011836.3  / EP2272865
Opposition(s)Opponent(s)01  27.05.2009  04.06.2009  ADMISSIBLE
AplaGen GmbH
Arnold-Sommerfeld-Ring 2
52499 Baesweiler / DE
Opponent's representative
Roth, Carla, et al, et al
König-Szynka-Tilmann-von Renesse
Patentanwälte Partnerschaft mbB
Postfach 11 09 46
40509 Düsseldorf / DE
 [N/P]
Former [2009/27]
Opponent(s)01  27.05.2009   
AplaGen GmbH
Arnold-Sommerfeld-Ring 2
52499 Baesweiler / DE
Opponent's representative
Roth, Carla, et al, et al
König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft Lohengrinstraße 11
D-40549 Düsseldorf / DE
01.07.2009Invitation to proprietor to file observations on the notice of opposition
26.04.2010Reply of patent proprietor to notice(s) of opposition
05.03.2012Cancellation of oral proceeding that was planned for 20.09.2012
23.03.2012Date of despatch of rejection of opposition
02.04.2012Legal effect of rejection of opposition [2012/32]
20.09.2012Date of oral proceedings
Fees paidRenewal fee
30.09.2005Renewal fee patent year 03
28.09.2006Renewal fee patent year 04
27.09.2007Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY27.08.2008
LU11.09.2008
MC30.09.2008
BG27.11.2008
[2015/36]
Former [2010/34]CY27.08.2008
LU11.09.2008
MC30.09.2008
BG27.11.2008
NL01.04.2009
Former [2010/32]LU11.09.2008
MC30.09.2008
BG27.11.2008
NL01.04.2009
Former [2009/26]MC30.09.2008
BG27.11.2008
NL01.04.2009
Former [2009/23]MC30.09.2008
BG27.11.2008
Former [2009/20]MC30.09.2008
Documents cited:Search[XD]DE2616086  (FRESENIUS CHEM PHARM IND) [XD] 1-5,12,15-20,22-26,33,36-41,43 * example 1 *;
 [X]DE3029307  (FRESENIUS CHEM PHARM IND [DE]) [X] 1-8,11-20,22-29,32-41,43,47 * example 1 *;
 [X]US5543332  (LIHME ALLAN O F [DK], et al) [X] 1-4,9,10,12,15-20,22-25,30,31,33,36-41,43 * examples 2,16 *;
 [PXD]WO02080979  (FRESENIUS KABI DE GMBH [DE], et al) [PXD] 1-49* example 7 *;
 [E]WO03074087  (BIOTECHNOLOGIE GES MITTELHESSE [DE], et al) [E] 1-14,16,19-49 * claim 1 *;
 [X]  - LARIONOVA N I ET AL, "CONJUGATION OF THE BOWMAN-BIRK SOYBEAN PROTEINASE INHIBITOR WITH HYDROXYETHYLSTARCH", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, CLIFTON, NJ, US, (1997), vol. 62, no. 2/3, ISSN 0273-2289, pages 175 - 182, XP001122297 [X] 1-4,12,15-20,22-25,33,36-41,43 * page 176 *

DOI:   http://dx.doi.org/10.1007/BF02787993
Examination   - THOMAS E. ET AL., CRIT CARE MED, (2000), vol. 28, pages 627 - 631
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.